
AIVF
An AI decision support system empowering clinics with Fertility Intelligence anytime, anywhere.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | $25.0m | Series A | |
Total Funding | 000k |
USD | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
% growth | - | 17 % | 233 % | 86 % |
EBITDA | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
AiVF is revolutionizing the In Vitro Fertilization (IVF) industry by providing an automated, AI-driven framework designed to enhance precision, reduce costs, and improve success rates. The company serves IVF clinics, embryology labs, and academic institutions, offering a data-driven approach that transforms IVF from an unpredictable process into a predictable science. Operating in the healthcare and biotechnology market, AiVF leverages its patented artificial intelligence technology to streamline the IVF treatment journey, making it more accessible and less emotionally draining for patients. The business model is based on providing advanced technological solutions to fertility clinics, which in turn helps them offer better outcomes to their patients. AiVF generates revenue through the sale of its AI-driven software and related services to these clinics and institutions.
Keywords: AI-driven, IVF, precision, cost-reduction, success rates, healthcare, biotechnology, embryology, automated, data-driven.
Tech stack
Investments by AIVF
Edit